TrialCPT: pharmacometrics & systems pharmacology2025

Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis.

Gilles Tiraboschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.